Stay updated on IRX-2 Regimen and Durvalumab Clinical Trial
Sign up to get notified when there's something new on the IRX-2 Regimen and Durvalumab Clinical Trial page.

Latest updates to the IRX-2 Regimen and Durvalumab Clinical Trial page
- Check4 days agoChange DetectedThere are no textual additions or deletions in the provided data for the page history. The study history content remains unchanged in terms of text.SummaryDifference0.1%

- Check11 days agoChange DetectedThe page's revision history now shows the latest system revision (v3.6.5) replacing the previous v3.6.4, reflecting a backend update to the record.SummaryDifference0.1%

- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedThe record history now lists a new revision, v3.6.4, in place of the previous v3.6.3, reflecting a new release of the page. This update records the latest version in the study record history.SummaryDifference0.1%

- Check47 days agoChange DetectedA new revision entry (v3.6.3) was added to the record history, updating the study record's version from the previous v3.6.2 and indicating an administrative update to the record.SummaryDifference0.1%

- Check54 days agoChange DetectedA new revision label 'Revision: v3.6.2' was added to the record history and the previous label 'Revision: v3.6.0' was removed, updating the page's version history metadata.SummaryDifference0.1%

- Check68 days agoChange DetectedA new revision v3.6.0 is added and the previous v3.5.5 revision is removed. The page now includes a notice that the study is no longer looking for participants, indicating recruitment has closed.SummaryDifference0.3%

Stay in the know with updates to IRX-2 Regimen and Durvalumab Clinical Trial
Enter your email address, and we'll notify you when there's something new on the IRX-2 Regimen and Durvalumab Clinical Trial page.